Skip to main content
Top
Published in: Medical Oncology 1/2013

01-03-2013 | Letter to the Editor

Non-invasive intraductal tubular adenoma, pyloric gland type, with malignant foci in the common bile duct

Author: Tadashi Terada

Published in: Medical Oncology | Issue 1/2013

Login to get access

Excerpt

Intraductal tubular neoplasm (ITN) of the pancreas is very rare; only several cases have been reported in the literature [1, 2]. However, ITN of the hepatobiliary system has not been reported. Herein reported is the first case of ITN, pyloric gland type, with malignant foci in the common bile duct (CBD). An 82-year-old man consulted our hospital because of obstructive jaundice. ERCP showed a mass in the lower CBD. A biopsy during ERCT revealed atypical tubules. Pancreaticoduodenectomy was performed. Grossly, a polypoid tumor (1 × 1 × 1 cm) was recognized in the lower CBD (Fig. 1a, b). Microscopically, the tumor consisted of tubular structures (adenoma of pyloric gland type) resembling pyloric glands (Figs. 1b, 2a). Foci of malignant transformation were seen in the periphery (Fig. 2b). The tumor was non-invasive. Histochemically, the tumor cells contained neutral and acidic mucins. Immunohistochemically, the tumor cells were positive for pancytokeratins (AE1/3 and CAM5.2), cytokeratin (CK) (34BE12, 5/6, 7, 8, 18, 19), CEA, CA19-9, CD56, HepPar1, MUC5AC and MUC6 (Fig. 3a). p53 was positive in carcinoma areas (Fig. 3b), but was negative in adenoma areas. Ki-67 labeling was 20 % in carcinoma areas, while it was 5 % in adenoma areas. The tumor was negative for CK 14, CK 20, NSE, EMA, HER2, vimentin, chromogranin, synaptophysin, CDX-2, MUC1 and MUC2. Non-invasive intraductal tubular adenoma (IPA), pyloric gland type, with malignant foci of the CMD was pathologically diagnosed. The patient is now free from tumor 5 months after the operation. Intraductal papillary, papillary mucinous, and oncocytic neoplasms occur both in pancreatic ducts and in bile duct [3, 4], reflecting similarity between both ducts. The present IPA expressed CK 34BE12 and CK5/6 in addition to pancreaticobiliary CKs (7, 8, 18, 19). The MUC-apomucin profile shows gastric type in the present case [5]. Expression of HepPar1 [3] and CD56 is strange. The expression of CEA, CA19-9, and p53 and high Ki-67 labeling in carcinoma areas indicates the malignant potential.
Literature
1.
go back to reference Terada T. Intraductal tubular carcinoma, intestinal type, of the pancreas. Pathol Int. 2009;59:53–8.PubMedCrossRef Terada T. Intraductal tubular carcinoma, intestinal type, of the pancreas. Pathol Int. 2009;59:53–8.PubMedCrossRef
2.
go back to reference Albores-Saavedra J, Sheahan K, O’Riain C, Shukla D. Intraductal tubular adenoma, pyloric type, of the pancreas: additional observations on a new type of pancreatic neoplasm. Am J Surg Pathol. 2004;28:233–8.PubMedCrossRef Albores-Saavedra J, Sheahan K, O’Riain C, Shukla D. Intraductal tubular adenoma, pyloric type, of the pancreas: additional observations on a new type of pancreatic neoplasm. Am J Surg Pathol. 2004;28:233–8.PubMedCrossRef
3.
go back to reference Terada T, Taniguchi M. Intraductal oncocytic papillary neoplasm of the liver. Pathol Int. 2004;54:116–23.PubMedCrossRef Terada T, Taniguchi M. Intraductal oncocytic papillary neoplasm of the liver. Pathol Int. 2004;54:116–23.PubMedCrossRef
4.
go back to reference Zen Y, Fujii T, Itatsu K, Nakamura K, Minato H, Kashima S, Kurumaya H, Katayanagi K, Kawashima A, Matsuda S, Niwa H, Mitsui T, Asada Y, Miura S, Ohta T, Nakanuma Y. Biliary papillary tumors share pathological features with intraductal papillary-mucinous neoplasm of the pancreas. Hepatology. 2006;44:1333–43.PubMedCrossRef Zen Y, Fujii T, Itatsu K, Nakamura K, Minato H, Kashima S, Kurumaya H, Katayanagi K, Kawashima A, Matsuda S, Niwa H, Mitsui T, Asada Y, Miura S, Ohta T, Nakanuma Y. Biliary papillary tumors share pathological features with intraductal papillary-mucinous neoplasm of the pancreas. Hepatology. 2006;44:1333–43.PubMedCrossRef
5.
go back to reference Adsay NV, Kloppel G, Fukushima N, et al. Intraductal neoplasm of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO Classification of tumours of the digestive system. Lyon: IARC; 2010. p. 304–13. Adsay NV, Kloppel G, Fukushima N, et al. Intraductal neoplasm of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO Classification of tumours of the digestive system. Lyon: IARC; 2010. p. 304–13.
Metadata
Title
Non-invasive intraductal tubular adenoma, pyloric gland type, with malignant foci in the common bile duct
Author
Tadashi Terada
Publication date
01-03-2013
Publisher
Springer US
Published in
Medical Oncology / Issue 1/2013
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-013-0459-1

Other articles of this Issue 1/2013

Medical Oncology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.